Where does Bioatlantis Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bioatlantis Limited ranks #45,179 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bioatlantis Limited hold?

Bioatlantis Limited holds 5 US utility patents granted between 2016 and 2023, spanning 5 technology areas.

What is Bioatlantis Limited's Innovation Score?

Bioatlantis Limited has an Innovation Score of 31.2 out of 100 (37th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bioatlantis Limited focus on?

Bioatlantis Limited's top technology area is Y02A (Technologies FOR Adaptation TO Climate Change) with 4 patents, ranking #1,056 of 3,645 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Bioatlantis Limited's patent grant rate increasing or decreasing?

Bioatlantis Limited's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Bioatlantis Limited's patents?

Bioatlantis Limited's patents average 24.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bioatlantis Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bioatlantis Limited

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2016–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: Y02A (Technologies FOR Adaptation TO Climate Change).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bioatlantis ranks #45,179 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#45,179
of 49,997 US assignees by volume: 37th percentile
by Innovation Score (31.2/100): 24.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45179 · Foreign Corporation #45,179 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,179/49,997
PHOTO-FINISH Bilab
CPC-NARROW Y02A · 5 areas
INNOV-THIN 31.2/100
CLAIMS-DENSE 24.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Bilab Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bioatlantis’s 31.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (20%) Velocity 2.2 pts (7%) Breadth 7.9 pts (25%) Claim depth 14.9 pts (48%)

Qualcomm Incorporated · highest

85
Bioatlantis · this assignee

31
3D Lighting… · lowest

7

What this shows Bioatlantis's Innovation Score is 31.2/100 (37th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bioatlantis?

Each dot is one of Bioatlantis’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bioatlantis’s own 24.8 claims/patent is ABOVE the 15.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Bioatlantis vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bioatlantis's grants concentrate

Bioatlantis Limited is a focused PatentsView assignee: 5 CPC subclasses with 80% of grants classified under Y02A (Technologies FOR Adaptation TO Climate Change). Peak complete grant year is 2020 (2 grants) versus a trough of 1 in 2016. By volume, Bioatlantis sits between Bilab Co., Ltd. and Bioinformatics Solutions Inc..

Bioatlantis's three-year grant acceleration

Bioatlantis Limited shows 1 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Bilab

5
Bill Archer

5
BIO Health Fronti…

5
Bioamber

5
Biocontrol Systems

5
Biofilm IP

5
Biofouling

5
Bioinformatics So…

5
Bioatlantis ◀

5

What this shows Bioatlantis holds 5 patents at rank #45,117, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bioatlantis

By rank, the assignees closest to #45,117 in granted patent volume.

Leaders in Y02A (Technologies FOR Adaptation TO Climate Change)

Other assignees with the most granted patents in Bioatlantis's primary technology class.

Bioatlantis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

31 37th percentile higher than 37% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Bioatlantis Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2019	1	20.0%
2020	2	40.0%
2023	1	20.0%

Which technologies does Bioatlantis Limited patent most?

Y02A - Technologies FOR Adaptation TO Climate Change 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 2

C08B - POLYSACCHARIDES; Derivatives Thereof 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bioatlantis Limited's patent record in context - here's where to go next.

Bioatlantis Limited's lead technology class is Y02A (Technologies FOR Adaptation TO Climate Change), 80% of its portfolio - see every assignee active in that class. Explore Y02A
Ranked #45,179 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bioatlantis Limited against Bilab Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 31.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.